People

Kelvin Droegemeier, PhD, was confirmed as director of the White House Office of Science and Technology Policy on January 2, filling a vacancy left by John Holdren, PhD, who departed in 2017. Previously, Droegemeier was a professor of meteorology and vice president of research at the University of Oklahoma in Norman. He also co-founded and directed the National Science Foundation (NSF) Science and Technology Center for the Analysis and Prediction of Storms and the NSF Engineering Research Center for Collaborative Adaptive Sensing of the Atmosphere. His research has focused on severe thunderstorms and tornadoes.

José Baselga, MD, PhD, began his role as executive vice president of Researchand Development Oncology at AstraZeneca in January. Most recently, Baselga was physician-in-chief and chief medical officer at Memorial Sloan Kettering Cancer Center in New York, NY. He has also served as associate director of Massachusetts General Hospital CancerCenter in Boston, MA, president of the American Association for Cancer Research, and editor-in-chief of Cancer Discovery. Baselga has studied and helped develop molecularly targeted agents for breast cancer.

Jacqualyn Fouse, PhD, became chief executive officer of Agios on February 1, replacing David Schenkein, now the company's executive chairman. Most recently, Fouse was executive chairman of the biopharmaceutical startup Dermavant. Before that, she spent 8 years at Celgene: She joined the company as chief financial officer, moved on to become president of global hematology, and later advanced to president and chief operating officer.

For more news on cancer research, visit Cancer Discovery online at http://cancerdiscovery.aacrjournals.org/CDNews.